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Abstract
Morphologic and biochemical changes occur during red cell storage prior to product expiry, and these changes may
hinder erythrocyte viability and function following transfusion. Despite a relatively large body of literature detailing the
metabolic and structural deterioration that occurs during red cell storage, evidence for a significant detrimental clinical
effect related to the transfusion of older blood is relatively less conclusive, limited primarily to observations in
retrospective studies. Nonetheless, the implication that the transfusion of old, but not outdated blood may have negative
clinical consequences demands attention. In this report, the current understanding of the biochemical and structural
changes that occur during storage, known collectively as the storage lesion, is described, and the clinical evidence
concerning the detrimental consequences associated with the transfusion of relatively older red cells is critically
reviewed. Although the growing body of literature demonstrating the deleterious effects of relatively old blood is
compelling, it is notable that all of these reports have been retrospective, and most of these studies have evaluated
patients who received a mixture of red cell units of varying storage age. Until prospective studies have been completed
and produce confirmative results, it would be premature to recommend any modification of current transfusion practice
regarding storage age.
In 1917, Frances Payton Rous and J.R. Turner identified that a citrate-glucose solution allowed for the preservation of a
whole blood unit for up to five days, thus facilitating the formative practice of blood banking[1]. Later, Loutit and Mollison
of Great Britain developed the first anticoagulant of the modern era, known as acid-citrate-dextrose (ACD)[1]. ACD
extended the shelf life of refrigerated blood to 21 days, and ACD remained in wide spread usage until the 1960s, when
it was replaced by citrate-phosphate-dextrose (CPD) and citrate-phosphate-dextrose-adenine (CPDA) solutions that
increased shelf life to 35 days and 42 days respectively. More recently, additive solutions containing saline, adenine, and
dextrose have been developed to augment red cell survival following transfusion, although without any direct increase
in storage duration[1,2].
It is now well appreciated, however, that a number of morphologic and biochemical changes occur during red cell storage
prior to product expiry, and these changes may hinder erythrocyte viability and function following transfusion. Despite
a relatively large body of literature detailing the metabolic and structural deterioration that occurs during red cell storage,
evidence for a significant detrimental clinical effect related to the transfusion of older blood is relatively less conclusive,
limited primarily to observations in retrospective studies. Nonetheless, the implication that the transfusion of old, but
not outdated blood may have negative clinical consequences demands attention. The purpose of this report is to describe
the current understanding of the biochemical and structural changes that occur during storage, known collectively as the
storage lesion, and to critically review the clinical evidence concerning the detrimental consequences associated with the
transfusion of relatively older red cells.
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The Storage Lesion
The term "storage lesion" has been traditionally used to
describe the progressive degradation of red cell structure
and function that occurs during conventional red cell stor-
age. It is useful, however, to also consider the accumula-
tion of bioreactive substances that occur during storage
under the umbrella of the storage lesion, as these sub-
stances may not be innocuous when transfused (Table 1).
Although the components of the storage lesion are well
described, the clinical relevance of these storage related
changes remains uncertain.
Changes to red cell structure and function
After 14 days of storage, byproducts of glycolytic metabo-
lism, lactic acid, and proteins accumulate. These byprod-
ucts, which in vivo are readily removed from circulation,
linger and result in structural and functional changes. As
storage time extends past 14 days, the red cells become
less pliable and therefore unable to traverse small vessels
of the microcirculation, ultimately resulting in decreased
oxygen delivery because the oxygenated red cells cannot
traverse the end-organ capillary beds. The change in shape
from standard biconcave disks to spiculated echinocytic
erythrocytes also makes the cells more aggregable, increas-
ing the likelihood of occluding the microcirculation, lead-
ing to tissue ischemia[3]. It is notable, however, that these
observations pertain to research performed with whole
blood, rather than red cell concentrates. In leukodepleted
red cell concentrates, Raat et al. found no significant red
cell deformation following six weeks of storage[4]. The
mechanism associated with the membrane changes lead-
ing to inability to maintain structure and stiffening is
likely related to the failure to maintain the cytoskeleton,
which is independent of adenosine triphosphate (ATP)
levels, since cellular membrane changes are observed
prior to the cellular decrease in ATP[3,5].
While structural changes are observed on the red cell sur-
face as storage time increases, biochemical changes occur
intracellularly, with decreases in enzymes and stored
energy concentrations that affect red blood cell function.
The metabolite and enzymatic regulator of hemoglobin,
2,3-diphsophoglycerate (2,3 DPG), has been shown to
decrease to near non-detectible levels within two weeks of
storage[6]. The decreased concentration in 2,3-DPG leads
to significant increases in hemoglobin's affinity for oxy-
gen, which ultimately decreases oxygen delivery to the
peripheral tissues upon re-infusion, because oxygen will
not unbind from hemoglobin. The red cell devoid of 2,3-
DPG can recover its normal levels within 72 hours after
infusion, and no irreversible effect in the function of the
red cell has been observed[7]. Given the delay to complete
recovery of ideal enzymatic function and oxygen unload-
ing in the peripheral tissue, the desired augmentation of
oxygen delivery following transfusion is not immediate,
but rather potentially delayed until 2,3-DPG levels are
normalized intracellularly[3].
ATP is not only an intracellular source of energy, but has
more recently been associated with vasodilation in
hypoxic conditions, whereby ATP is released from the
RBC and ultimately initiates a signaling cascade that stim-
ulates nitric oxide production[6]. As ATP levels decrease
during storage, active transport, antioxidant reactions,
and membrane phospholipid distribution and other
energy requiring reactions decrease, causing the cell to
become more vulnerable to a stressing environment.
Recent studies have shown as much as a 60% decrease in
intracellular ATP levels with storage greater than 5
weeks[6]. In a study by Raat et al., increasing intracellular
ATP levels improved oxygen capacity, suggesting that ATP
concentration (and indirectly storage age) affects cellular
oxygen carrying capacity and oxygen delivery[4].
Changes in red cell storage medium
The first evidence of an immunomodulative effect associ-
ated with allogeneic blood transfusion was documented
by Opelz et al. in 1973, when improved graft function and
Table 1: Characteristics of the storage lesion.
Storage Effect Consequences
Changes to red cell structure and function
Cellular membrane changes Erythrocytes change shape
Decreased survivability
Decreased 2,3-diphsophoglycerate Increased oxygen affinity
Decreased oxygen delivery
Decreased adenosine triphosphate Erythrocytes change shape
Increased cell fragility
Less resistance to oxidative stress
Changes in red cell storage medium
Accumulation of bioactive substances
(cytokines, histamines, lipids, enzymes)
Increased oxidative environment
Febrile transfusion reactions
Immunologic activation/suppressionScandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:35 http://www.sjtrem.com/content/17/1/35
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a lower incidence of graft rejection were observed in renal
transplant recipients who received a blood transfusion
prior to transplantation[8]. Immunomodulation related
to blood transfusion is presumed to be related to the accu-
mulation of various soluble bioactive substances, prima-
rily but not exclusively derived from passenger leukocytes
contained in the donor unit. This effect can vary from
immunosupression, as evident by increased association
with nosocomial and post-operative infections, increased
cancer recurrence, and enhanced allograft survival, to
immune activation, as evident by hemolytic transfusion
reactions, transfusion-associated graft-versus-host disease,
transfusion-related lung injury, and possible autoimmune
diseases[9]. Although the mechanism of immunomodu-
lation is largely unknown, the infusion of the degradative
components of passenger leukocytes, including hista-
mine, lipids, cytokines, and human leukocyte antigen
(HLA) is implicated. The bioactive soluble molecules are
released from the leukocytes during storage and accumu-
late as storage time lengthens[10].
As the passenger leukocytes contained in a typical red cell
unit are implicated in the deleterious effect of older blood,
it follows that leukoreduction of red cell concentrates
(which is performed on a universal basis in many coun-
tries), might mitigate this effect. Biffl et al., however,
observed that although the plasma from nonleukore-
duced aged stored blood delayed neutrophil apoptosis (a
proinflammatory phenomenon) and primed neutrophils
for cytotoxicity, plasma from stored blood that had under-
gone prestorage leukoreduction did not, in fact, modify
this effect[11]. Immunization is proposed to be related to
HLA-DR compatibility and when at least one antigen
from the donor matches the recipient, immune tolerance
is observed; on the contrary, when there is complete mis-
match of HLA-DR antigens, immunization is acti-
vated[12].
Effect of storage on tissue oxygenation
In clinical practice, blood is often transfused in an effort
to augment tissue oxygen delivery. Nonetheless, there is
some question as to the effectiveness of transfusion in this
regard, particularly related to red cell storage. Raat et al.
demonstrated that blood stored for longer periods of time
(5 weeks) resulted in diminished oxygen delivery capacity
to the gut microcirculation of anemic oxygen-supply
dependent rats, while relatively fresh blood, stored only
several days, and intermediate-aged blood, stored several
weeks, improved oxygen delivery[4]. Likewise, Fitzgerald
et al. demonstrated that blood stored for 28 days did not
improve oxygen delivery and consumption when trans-
fused to rats while transfusion of blood stored only 3 days
did, in fact, improve oxygen delivery[13]. These observa-
tions in rats, however, may not be extrapolative to
humans. Rat red cells age approximately four times faster
than human red cells in storage, and fail to regenerate 2,3-
DPG when treated with a rejuvenation solution, in con-
trast to human red cells[14].
In human studies, observations have been less conclusive.
Marik et al. observed a decreased gastric pH, a measure of
gastric mucosal oxygenation status, in patients receiving
blood that had been stored beyond 15 days[15]. Walsh et
al., however, were unable to replicate the results of Marik
et al, which were identified in the course of post hoc anal-
ysis. In a prospective, double-blind trial of critically ill
intensive care unit patients randomized to receive leu-
kodepleted red cells stored either ≤ 5 days or ≥ 20 days,
Walsh et al. observed no significant differences in gastric
pH measurements or other indices of global tissue oxy-
genation[16]. Recently, Kiraly et al. evaluated peripheral
tissue oxygenation as measured by near infrared spectros-
copy during the course of red cell transfusion[17]. The
authors observed that patients transfused with blood
stored 21 days or longer had a statistically significant
decline in tissue oxygen saturation compared with those
transfused with blood less than 21 days old. Whether or
not the magnitude of the observed decline is clinically
meaningful in any way remains uncertain.
Red Cell Storage and Clinical Outcomes
The association between the transfusion of relatively older
blood and morbidity and mortality has been demon-
strated in multiple retrospective studies utilizing various
study designs (Table 2). In 1997, Purdy et al. reported the
association between blood storage age and survival
among 31 septic ICU patients[18]. No differences were
observed between survivors and nonsurvivors concerning
age, gender, ICU length of stay, APACHE II score, or total
number of red cell units transfused. However, the median
age of red cell units transfused to survivors during sepsis
was 17 days (range 535) versus 25 days (range 936) for
nonsurvivors (P < 0.0001).
In 1999, Zallen et al. examined the association between
red cell storage age and multiple organ failure (MOF) in a
matched case-control study concerning trauma patients
that received between 6 and 20 units of red cells in the first
12 hours following injury[19]. No difference in ISS or
transfusion requirement was observed between MOF pos-
itive (n = 23) and MOF negative (n = 40) groups. The
authors identified that the mean age of transfused blood
was significantly greater in the MOF positive patients
(30.5+/-1.6 days versus 24+/-0.5 days). Multivariate anal-
ysis identified mean age of blood, number of units older
than 14 days, and number of units older than 21 days as
independent risk factors for MOF.
From the same institution, Offner et al. evaluated the
association between transfusion of relatively older bloodScandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:35 http://www.sjtrem.com/content/17/1/35
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and post-injury infection in a similar patient cohort[20].
In this study of 61 patients who each received between 6
and 20 units of red cells in the first 12 hours after injury,
patients who developed infections were found to have
received 11.7 +/- 1.0 and 9.9 +/- 1.0 units of red cells older
than 14 and 21 days, respectively, compared with 8.7 +/-
0.8 and 6.7 +/- 0.08 units in patients who did not develop
infections (both p < 0.05). Multivariate analysis demon-
strated age of blood to be an independent risk factor for
post-injury infection.
Keller et al. examined the influence of blood storage age
on hospital length of stay in a trauma patient cohort of 86
patients[21]. Univariate analysis demonstrated that the
number of units of transfused blood older than 14 days
correlated significantly with hospital length of stay. They
also evaluated the total number of units transfused, mean
age of blood, age of the oldest unit, and average of the two
oldest units for associations with length of stay; none cor-
related significantly with length of stay. Multivariate anal-
ysis was then performed and indicated that the number of
units of blood older than 14 days remained significantly
associated with increased length of stay.
As evident in the studies described above, the evaluation
of the independent role of storage age on outcomes in
patient populations that received a heterogeneous distri-
bution of relatively old and young blood is far from
straightforward. Utilization of measures of central ten-
dency, such as the mean or median age of all units trans-
fused to a given patient, may simplify the analysis from a
statistical standpoint, but is flawed in that it makes an
assumption of mechanism, whereby the transfusion of
relatively younger units engenders a protective (or a
watering down) effect, offsetting the proposed deleterious
effect of older blood. Given the present understanding of
the storage lesion, there is no evident rationale for the
assumption of such. Alternatively, analyses that focus on
the volume of old blood transfused, while avoiding this
assumption of mechanism, are hindered by the con-
founding of total transfusion volume. The observed asso-
ciations between the transfusion of relatively older blood
and morbidity or mortality may actually be more reflec-
tive of the residual effect of total transfusion volume
rather than blood storage age, as transfusion volume and
transfusion storage age are necessarily linked variables.
The more units of blood a patient receives the greater like-
lihood that the mean age of those units will be older. Fur-
ther, given that receipt of larger units of blood likely
reflects more serious injuries, and therefore a greater like-
lihood of morbidity and mortality, any adverse associa-
tion with older mean age may simply reflect higher injury
severity. It is therefore important to consider not only the
age of the blood transfused but also the volume and these
measures should not be treated in an independent man-
ner. If the associations between older blood and out-
comes as outlined above were actually secondary to the
residual confounding of transfusion volume, the associa-
tions between outcome and the volume of young blood
transfused would be expected to be similar.
With this in mind, we recently evaluated the association
between mortality and the transfusion of both older and
younger blood, respectively[22]. Among 1,813 severely
injured patients (mean ISS 26) admitted to the trauma
service of the University of Alabama at Birmingham Uni-
Table 2: Clinical outcome studies reviewing the effects of red cell storage age, in order of publication
Author Study Population No. Patients Major Conclusion
Purdy et al.[18] Septic ICU patients 31 Patients who died received older RBC
Vamvakas et al.[31] CABG patients 416 Transfusion of RBC with longer storage time 
associated with pneumonia
Zallen et al.[19] Trauma patients who received 620 RBC in the 
first 12 hours post-injury
63 Patients who developed MOF received older blood 
(30 vs. 24 days)
Vamvakas et al.[32] CABG patients 268 Transfusion of old RBC was not associated with 
increased morbidity or mortality
Offner et al.[20] Trauma patients who received 620 RBC in the 
first 12 hours post-injury
62 Transfusion of old blood was associated with 
increase risk of infection
Keller et al.[21] Trauma patients who received ≥1 RBC within 48 
hours of admission
86 Older RBC were associated with longer hospital 
length of stay
Murrell et al.[33] Trauma patients who received ≥1 RBC 275 Patients who received older RBC had longer length 
of ICU stay but no increased in-hospital mortality
Koch et al.[24] CABG patients who received exclusively young 
or old blood
6,002 Patients receiving old RBC had higher mortality 
(short and long term)
Weinberg et al.[22] Trauma patients who received ≥1 RBC within the 
first 24 hours post-injury
1,813 Blood storage age potentiated the increased odd of 
mortality seen with larger volumes of transfusion
Weinberg et al. [23] Less severely injured trauma patients who 
received no RBC in the first 48 hours post-injury
1,624 Transfusion of old blood was associated with 
increased mortality, renal failure, and pneumonia
RBC = red blood cell unitScandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:35 http://www.sjtrem.com/content/17/1/35
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versity Hospital, who received one or more units of blood
within the initial 24 hours of hospitalization, we deter-
mined that while larger volumes of blood, irrespective of
storage age, were associated with an increased odds of
mortality, the transfusion of blood stored beyond 14 days
appeared to significantly potentiate this association, sug-
gesting the existence of a veritable association between
storage age and outcome.
In a second study, we evaluated the relationship between
blood storage age and adverse outcomes in a relatively less
injured population[23]. This cohort of 1,624 trauma
patients comprised those with blunt mechanism of injury,
ISS < 25, and no blood transfusions administered within
the first 48 hours of hospital admission. Similar to our
previous work, we determined the effect of both young
and old blood on outcome, respectively. We observed that
the receipt of old blood was significantly associated with
mortality, acute renal dysfunction, and pneumonia,
whereas the receipt of young blood was not, further sug-
gesting that transfusion of older blood is independently
associated with outcome, even in relatively less severely
injured patients.
Nonetheless, the methodological difficulties presented by
patients receiving a heterogeneous distribution of old and
young blood remain; analyses limited to those patients
that received exclusively old versus exclusively young
blood may simplify things considerably. In our study con-
cerning 1,813 trauma patients, we performed a subgroup
analysis concerning only those patients who received
exclusively young or old blood, and found that among
those patients receiving a total of 3 or more red cell units,
receipt of old blood was associated with an over 2-fold
increased odds of death[22]. Koch et al. performed a sim-
ilar analysis concerning 6,002 cardiac surgery patients,
and observed that patients in the older blood group had
significantly higher incidences of in-hospital mortality,
intubation beyond 72 hours, renal failure, and sepsis[24].
Again, however, the coupling of storage age and volume
of transfusion must be acknowledged. Although the distri-
bution of transfusion volume in both the young and old
groups in this study (and in our subgroup analysis) as rep-
resented by the mean was similar between groups, it
remains plausible that transfusion volume remains a rele-
vant residual confounder. In fact, the report by Koch et al.
has been vocally criticized for failure to adequately
account for multiple potential confounders including dif-
ferences concerning total transfusion volume, underlying
comorbidities, and ABO blood groups between
groups[25,26].
It is notable that in our reported experience described
above, all patients were transfused with blood that had
undergone prestorage leukoreduction[22,23]. Although
leukoreduction has well documented efficacy related to
specific clinical circumstances, a generalized benefit
remains unproven[27]. Indeed, Nathens et al. performed
a randomized trial comparing prestorage leukoreduced
versus standard nonleukoreduced transfusions to evaluate
whether or not leukoreduction might improve outcomes
among trauma patients, and found no difference in mor-
tality or infectious morbidity among the 268 patients eli-
gible for analysis[28]. Our clinical experience as described
above demonstrates associations concerning both mor-
bidity and mortality with older blood despite universal
leukoreduction, further suggesting that the existence of a
clinically relevant benefit of leukoreduction in the trauma
setting remains doubtful.
Summary
Although the growing body of literature demonstrating
the deleterious effects of relatively old blood is compel-
ling, we must be mindful that all of these reports have
been retrospective, and most of these studies have evalu-
ated patients who received a mixture of red cell units of
varying storage age. As highlighted above, the difficulty in
distinguishing the effect of storage age from the effect of
transfusion volume in these studies is not insignificant. In
our own work, we have employed statistical analysis that
we feel best attenuates the potential residual confounding
of transfusion volume. It remains quite possible, however,
that prospective evaluation of the effect of storage age on
outcome might yield contradictory results.
Certainly, prospective confirmation of the effect of blood
storage on morbidity and mortality is now warranted.
Schulman et al. attempted such a trial in the setting of a
single-center Level 1 trauma center, randomizing patients
to receive exclusively young (<11 days) versus old (>20
days) blood during the first 24 hours of hospitaliza-
tion[29]. Unfortunately, in 1 year they were only able to
enroll a small number of patients secondary to limitations
of the blood bank. It is reasonable to expect that other
institutions would face a similar challenge given the tight
supply of blood. It is clear that only inter-institutional
cooperation in the form of a multi-institutional trial will
be successful in the recruitment of enough patients for a
robust analysis. Hebert et al. performed a multi-center fea-
sibility study in Canada, and reported that a large scale
study would be feasible, but challenged by the mainte-
nance of a sufficient blood supply to allow for randomi-
zation between old and young groups with a limited
number of subsequent group crossovers[30]. Until such
prospective studies have been completed and produce
confirmative results, it would be premature to recom-
mend any modification of current transfusion practice
regarding storage age. Nonetheless, the implication that
the transfusion of blood of relatively longer storage agePublish with BioMed Central    and   every 
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may have negative consequences demands attention and,
most importantly, further rigorous evaluation.
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